Treatment of Heart Palpitations
The recommended treatment for heart palpitations depends critically on whether an arrhythmia is documented and the patient's hemodynamic stability, with lifestyle modifications as first-line therapy for benign cases and immediate intervention required for life-threatening arrhythmias. 1, 2
Initial Assessment and Risk Stratification
The first priority is determining hemodynamic stability and identifying life-threatening conditions 1, 2:
- Immediate intervention is required if palpitations are accompanied by syncope, pre-syncope, chest pain, hypotension (systolic BP ≤90 mmHg), heart failure, or heart rate ≥150 beats/min 3, 1
- Obtain a 12-lead ECG immediately during the initial evaluation to capture any arrhythmia present and identify baseline abnormalities 1, 4
- Assess for precipitating factors including caffeine, alcohol, exercise, stress, or medications 2
Conservative Management for Benign Palpitations
For hemodynamically stable patients without documented dangerous arrhythmias, lifestyle modifications should be the first-line approach before considering pharmacological therapy: 2
- Eliminate all stimulants: Stop caffeine consumption, discontinue alcohol intake, and cease cigarette smoking 2
- Liberalize fluid and salt intake for patients with orthostatic symptoms 2
- Use support stockings to improve venous return in patients with postural symptoms 2
- Gradually increase physical activity in sedentary patients, as physical inactivity predicts palpitations 2
- Address psychological comorbidities including depression and anxiety, which are significant predictors of palpitations 2
Treatment Based on Documented Arrhythmia Type
Ventricular Tachycardia (VT)
For sustained VT with hemodynamic compromise: 3
- Beta-blockers are first-line therapy unless contraindicated 3
- Lidocaine (lignocaine) is the drug of first choice if beta-blockers fail or high risk of recurrent ventricular fibrillation: 1 mg/kg IV bolus, may repeat half-dose every 8-10 minutes to maximum 4 mg/kg, followed by infusion of 1-3 mg/min 3
- Amiodarone may be superior for recurrent sustained VT requiring cardioversion: 5 mg/kg (300 mg) IV over 1 hour, followed by 900-1200 mg over 24 hours 3
- Synchronized DC cardioversion (100J, 200J, 360J) if hemodynamically significant VT persists 3
- Hospitalization is required for patients with sustained VT to initiate antiarrhythmic therapy 1, 2
Ventricular Fibrillation
Immediate defibrillation is the priority - pharmacological treatment is secondary to early defibrillation 3
- Magnesium may be effective, particularly with acute myocardial infarction: 8 mmol bolus followed by 2.5 mmol/h infusion 3
Supraventricular Tachycardia (SVT)
Management depends on hemodynamic stability: 1, 2
- Vagal maneuvers should be attempted first in stable patients 1, 2
- Beta-blockers are effective for rate control and rhythm conversion 3, 1
- Catheter ablation should be considered for recurrent episodes 1, 2
Atrial Fibrillation
Implement either rate control or rhythm control strategies with stroke risk assessment: 3, 1, 2
- Beta-blockers and digoxin are effective for rate control in many cases 3
- Amiodarone may be more efficacious for terminating the arrhythmia 3
- For vagally-mediated AF: Avoid adrenergic blocking drugs or digitalis as they may worsen symptoms 2
- For adrenergically-induced AF: Beta-blockers are the initial treatment of choice 2
- Cardioversion may be used but should only be employed if mandatory, as recurrences are common 3
Diagnostic Testing to Guide Treatment
When the arrhythmia is not captured on initial ECG: 1, 4
- 48-hour ambulatory ECG monitoring is first-line for frequent or sustained palpitations 1, 4
- Event recorder or wearable loop recorder for less frequent episodes 1, 4
- Implantable loop recorder for rare episodes in low-risk patients 2, 4
- Echocardiography to exclude structural heart disease, especially with sustained palpitations or concerning symptoms 1, 4
- Exercise stress testing when palpitations are triggered by exertion 4
Indications for Specialist Referral
Immediate cardiology/electrophysiology referral is necessary for: 1, 2, 4
- Palpitations with syncope, pre-syncope, or dyspnea 1, 2
- Evidence of structural heart disease 1, 4
- Documented complex arrhythmias 1
- Wide complex tachycardia of unknown origin 4
- Pre-excitation on resting ECG with history of paroxysmal regular palpitations 4
- Wolff-Parkinson-White syndrome 4
Critical Pitfalls to Avoid
- Never use calcium channel blockers (verapamil, diltiazem) to terminate wide-QRS-complex tachycardia of unknown origin, especially with myocardial dysfunction 2
- Do not overlook non-cardiac causes such as hyperthyroidism, stimulant use, or anxiety 2
- Recognize that many patients with palpitations have no arrhythmias on ambulatory ECG at the time of symptoms, highlighting the importance of proper diagnostic correlation 2